Morphine kinetics during and after renal transplantation

Area of Science:

• Pharmacology
• Nephrology
• Transplantation

Background:

• Morphine is a widely used analgesic.
• Renal function significantly impacts drug metabolism and excretion.
• Understanding morphine pharmacokinetics in renal transplant recipients is crucial for safe and effective pain management.

Purpose of the Study:

• To investigate plasma morphine concentrations and pharmacokinetic parameters in renal transplant patients compared to control subjects.
• To assess the impact of early post-transplant renal function on morphine elimination.

Main Methods:

• Plasma morphine levels were quantified using radioimmunoassay.
• Pharmacokinetic analysis included elimination half-life (t1/2), area under the curve (AUC), and plasma clearance.
• Patients undergoing renal transplantation and healthy controls were studied.

Main Results:

• Plasma morphine concentrations initially decreased in both groups.
• Transplant patients showed a delayed fall in morphine levels for 3-5 hours post-transplantation.
• Morphine elimination half-life normalized upon recovery of renal function, with higher AUC and lower plasma clearance observed in transplant patients.

Conclusions:

• The kidney plays a significant role in morphine elimination.
• Transient impairment of morphine clearance occurs in renal transplant patients during the early post-operative period.
• Recovery of renal function is associated with normalization of morphine pharmacokinetics.